How SARS-COV-2 spreads (Re) and why there are differences between countries ?
An explanation for kids based on the astonishing new study of @firefoxx66 @richardneher and colleagues pubmed.ncbi.nlm.nih.gov/40233303/
2) With a really fast-spreading virus going around, like the one that causes COVID-19, when someone gets sick, they can pass the virus to other people. But some sick people end up spreading it to a lot more people than others.
2) The scientists in this study wanted to figure out how the virus is spreading and how much it's spreading from person to person. To do this, they looked at the genetic code, or the "DNA", of the virus.
Whenever the virus infects someone new, it can change a little bit.
3) So if two people have the exact same virus DNA, it means the virus must have spread directly from one person to the other, without changing much.
The scientists grouped all the virus DNA samples into clusters of identical ones.
4) The size of these clusters tells them how the virus is spreading. If there are a lot of big clusters, it means the virus is spreading a lot from person to person. But if there are mostly small clusters, it means the virus isn't spreading as much.
5) By looking at these virus DNA clusters, the scientists were able to estimate two important numbers:
1. The average number of people each sick person infects (called R) 2. How much the virus spreads differently between people (called k)
6) The scientists found that in some countries, the virus wasn't spreading as much between people, while in other countries, it was spreading more unevenly, with some people infecting a lot more people than others.
Thanks for reading 🙏
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Doctor, I'm confused 🤔
I have a high level of antibodies, yet I'm still experiencing long COVID. Why is that?
"The ANTIBODIES PARADOX in LONG COVID Condition: Unraveling the Disconnect Between Humoral Immunity and Chronic Illness" nature.com/articles/s4146…
2) The finding in this study of persistently higher anti-N antibody levels in people with Post-Covid Condition (PCC) compared to those with acute infection only, does seem paradoxical at first glance.
3) A few points on this:
▶️ The study suggests this may indicate "altered immune activation or viral persistence" in people with PCC, rather than just a stronger antibody response per se.
2) T-cells are like the superheroes of our immune system - they work hard to protect us from germs and viruses.
When a virus like SARS-COV-2 gets into our body, the T cells spring into action. There are different types of T cells, each with a special job to do.
3) - Some T cells are like the fighters, killing off the virus-infected cells.
- Other T cells are the coordinators, telling the other immune cells what to do.
- There are also T cells that act like the police, making sure the immune response doesn't go overboard.
2) The most important immune components in the nasal tissue for fighting COVID-19 are:
▶️ Monocytes and neutrophils
- These immune cells moved into the area under the nose lining during active COVID-19 infection and helped protect the underlying lymphoid tissue.
3)▶️ Macrophages
- As people recovered from COVID-19, macrophages started to help repair the nasal tissue.
▶️ Germinal centers and B cells
- The specialized germinal center structures in the nose contained active B cells that were producing antibodies against the COVID-19 virus
Brain scans of Long COVID patients showed reduced volumes in critical brainstem regions like superior and middle cerebellar peduncles, along with decreased connectivity.
These structural and functional changes were linked to motor ...
2) ... sensory, and autonomic dysfunction in patients. Researchers propose a "Broken Bridge Syndrome" where COVID-19 disrupts the vital connection between the brainstem and cerebellum, contributing to the diverse neurological symptoms of Long COVID.
3) Figure 4 clearly shows the structural dissolution and volume reduction of the 4th ventricle in the superior cerebellar peduncle in one and the same COVID-19 patient.
This study looked at the immune response to COVID-19 vaccines and natural infection. It found that both vaccines and prior infection can generate strong T cell responses that recognize different parts of the virus. biorxiv.org/content/10.110…
2) These T cell responses are important for fighting off the virus, even as it mutates.
The study first looked at people who got the mRNA COVID-19 vaccines. It found that the vaccines quickly induced T cells that could produce multiple immune molecules like interferon-gamma ...
3) ...TNF-alpha, and IL-2. This shows the vaccines are generating a robust and versatile T cell response.
The study then looked at how well the T cell response from vaccines and prior infection could recognize different variants of the virus.
CANCER+ COVID-19 !
The Increased Risk of Viral Co-Infections (Herpesviruses (HHV) and Measles Virus (MeV)) in Cancer Patients with COVID-19 jenci.springeropen.com/articles/10.11…
2) Herpes viruses, like the one that causes cold sores, were 3 times more common in cancer patients with COVID-19 compared to others. Nearly 30% of cancer patients with COVID-19 had the herpes virus reactivate, while it didn't reactivate at all in non-cancer patients with COVID
3) The Epstein-Barr virus, which can cause mononucleosis, also reactivated in 20% of cancer patients, but only 5% of non-cancer patients.
Measles antibodies were found in 78% of cancer patients with COVID-19, much higher than the 17.5% in non-cancer COVID-19 patients.